RIM
OREX

RS Investment Management’s Orexigen Therapeutics, Inc. OREX Stock Holding History

RS Investment Management’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-222,964
Closed -$9.5M – 421
2014
Q3 		$9.5M Buy
222,964
+5,050
+2% +$271K 0.09% 236
2014
Q2 		$13.5M Sell
217,914
-4,445
-2% -$258K 0.11% 208
2014
Q1 		$14.5M Buy
222,359
+29,330
+15% +$1.98M 0.09% 207
2013
Q4 		$10.9M Buy
193,029
+42,450
+28% +$2.39M 0.07% 215
2013
Q3 		$9.25M Buy
150,579
+10,310
+7% +$698K 0.06% 207
2013
Q2 		$8.21M Buy
+140,269
New +$8.63M 0.06% 214

Other funds holding OREX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

RS Investment Management's OREX Position: Q4 2014 in Review

RS Investment Management sold out of Orexigen Therapeutics, Inc. (OREX) in Q4 2014, closing a stake of 222,964 shares — an estimated $9.5M sold.

RS Investment Management first reported a position in OREX in Q2 2013 and held it in 6 quarters. The position peaked at $14.5M in Q1 2014. 147 funds tracked by Wall St. Rank hold OREX as of Q4 2014.

  • RS Investment Management reported no remaining Orexigen Therapeutics, Inc. position as of Q4 2014 after selling out during the quarter.
  • RS Investment Management sold 222,964 Orexigen Therapeutics, Inc. shares in Q4 2014, an estimated $9.5M.
  • RS Investment Management first reported a position in Orexigen Therapeutics, Inc. in Q2 2013 and held it in 6 quarters.
  • RS Investment Management's Orexigen Therapeutics, Inc. position peaked at $14.5M in Q1 2014.
  • 147 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q4 2014.

Based on RS Investment Management's 13F filing for Q4 2014, filed 12 Feb 2015.